BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 24820740)

  • 1. Cardiotoxicity: cisplatin and long-term cancer survivors.
    Patanè S
    Int J Cardiol; 2014 Jul; 175(1):201-2. PubMed ID: 24820740
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiotoxicity: trastuzumab and cancer survivors.
    Patanè S
    Int J Cardiol; 2014 Dec; 177(2):554-6. PubMed ID: 25205483
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardiotoxicity: anthracyclines and long term cancer survivors.
    Patanè S
    Int J Cardiol; 2014 Oct; 176(3):1326-8. PubMed ID: 25129289
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardio-Oncology: An Update on Cardiotoxicity of Cancer-Related Treatment.
    Lenneman CG; Sawyer DB
    Circ Res; 2016 Mar; 118(6):1008-20. PubMed ID: 26987914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multimodality assessment and treatment of chemotherapy-induced cardiotoxicity.
    Storozynsky E
    Future Cardiol; 2015 Jul; 11(4):421-4. PubMed ID: 26238563
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiovascular Toxicities in Pediatric Cancer Survivors.
    Ryan TD; Nagarajan R; Godown J
    Cardiol Clin; 2019 Nov; 37(4):533-544. PubMed ID: 31587793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological foundations of cardio-oncology.
    Minotti G; Salvatorelli E; Menna P
    J Pharmacol Exp Ther; 2010 Jul; 334(1):2-8. PubMed ID: 20335321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term survivors of ovarian malignancies after cisplatin-based chemotherapy; cardiovascular risk factors and signs of vascular damage.
    de Vos FY; Nuver J; Willemse PH; van der Zee AG; Messerschmidt J; Burgerhof JG; de Vries EG; Gietema JA
    Eur J Cancer; 2004 Mar; 40(5):696-700. PubMed ID: 15010070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging methods for detection of chemotherapy-associated cardiotoxicity and dysfunction.
    Ong DS; Scherrer-Crosbie M; Coelho-Filho O; Francis SA; Neilan TG
    Expert Rev Cardiovasc Ther; 2014 Apr; 12(4):487-97. PubMed ID: 24650314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strain imaging to detect cancer therapeutics-related cardiac dysfunction: are we there yet?
    Collier P; Koneru S; Tamarappoo B; Griffin B
    Future Cardiol; 2015 Jul; 11(4):401-5. PubMed ID: 26239809
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardiovascular events in survivors of high-dose chemotherapy for germ cell tumors.
    Ishioka J; Fujii Y; Kageyama Y; Fukuda H; Higashi Y; Kihara K
    Int J Urol; 2008 Jul; 15(7):642-5. PubMed ID: 18643784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular risk in long-term survivors of testicular cancer.
    Vaughn DJ; Palmer SC; Carver JR; Jacobs LA; Mohler ER
    Cancer; 2008 May; 112(9):1949-53. PubMed ID: 18338810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should the 'echo guidelines' be followed in cancer patients?
    Herrmann J; Yang EH
    Future Oncol; 2015; 11(14):2021-5. PubMed ID: 26198830
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term cardiovascular risk following platinum-based chemotherapy for germ cell tumors.
    Evans C; Williams M; Mazhar D
    Future Oncol; 2010 Sep; 6(9):1365-8. PubMed ID: 20919820
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiotoxicity after childhood cancer: beginning with the end in mind.
    Lipshultz SE; Adams MJ
    J Clin Oncol; 2010 Mar; 28(8):1276-81. PubMed ID: 20142585
    [No Abstract]   [Full Text] [Related]  

  • 16. Curing Cancer, Saving the Heart: A Challenge That Cardioncology Should Not Miss.
    Cardinale D; Biasillo G; Cipolla CM
    Curr Cardiol Rep; 2016 Jun; 18(6):51. PubMed ID: 27108361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer survivorship: cardiotoxic therapy in the adult cancer patient; cardiac outcomes with recommendations for patient management.
    Steingart RM; Yadav N; Manrique C; Carver JR; Liu J
    Semin Oncol; 2013 Dec; 40(6):690-708. PubMed ID: 24331191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing cardio-oncology programs for cancer patients.
    Francis SA; Asnani A; Neilan T; Scherrer-Crosbie M
    Future Oncol; 2015; 11(14):2011-5. PubMed ID: 26198828
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardio-oncology Part I: chemotherapy and cardiovascular toxicity.
    O'Hare M; Sharma A; Murphy K; Mookadam F; Lee H
    Expert Rev Cardiovasc Ther; 2015 May; 13(5):511-8. PubMed ID: 25843285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Onco-cardiology: Present and future.
    Sueta D; Hokimoto S
    Int J Cardiol; 2016 Jul; 215():38-40. PubMed ID: 27107544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.